Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroMetrix

4.37
+0.0000
Volume:1.07K
Turnover:4.68K
Market Cap:8.93M
PE:-0.99
High:4.37
Open:4.36
Low:4.35
Close:4.37
Loading ...

Company Profile

Company Name:
NeuroMetrix
Exchange:
NASDAQ
Establishment Date:
1996
Employees:
26
Office Location:
4B Gill Street,Woburn,Massachusetts,United States
Zip Code:
01801
Fax:
- -
Introduction:
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Directors

Name
Position
Shai N. Gozani
Chairman of the Board, Chief Executive Officer, President and Secretary
David E. Goodman
Director
David Van Avermaete
Director
Nancy E. Katz
Director

Shareholders

Name
Position
Shai N. Gozani
Chairman of the Board, Chief Executive Officer, President and Secretary
Thomas T. Higgins
Senior Vice President, Chief Financial Officer and Treasurer